Our esteemed BOD member Kevin Buchi's Tetralogic, of which he is CEO and President of the BOD has been on a nosedive for months. Last Wed/Thurs it dropped 70% in one day. There is no reason he should sit on our board. Their main goal is HBV and I don't see how he provides any value to BLT and it's aspirations for the HBV space.
$6.25 to .28====just another case of creating shareholder value. Note that TLOG was a KSS buy.
- Forums
- ASX - By Stock
- BLT
- Buchi and TLOG
Buchi and TLOG
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online